Association of Rivaroxaban vs Apixaban With Major Ischemic or Hemorrhagic Events in Patients With Atrial Fibrillation

Post time 2021-12-29 21:57:16

journal：JAMA

Authors：Wayne A. Ray; Cecilia P. Chung; C. Michael Stein; Walter Smalley; Eli Zimmerman; William D. Dupont; Adriana M. Hung; James R. Daugherty; Alyson Dickson; Katherine T. Murray

Published date：2021-12-21

DOI：10.1001/jama.2021.21222

Article link：http://dx.doi.org/10.1001/jama.2021.21222

Article Source：American Medical Association (AMA)。

Remark：Thanks

Post time 2021-12-29 21:57:17

: This post has been completed
Completed attachments will be deleted within 24 hours.

Post time 2021-12-30 01:33:22

: This post has been completed
Completed attachments will be deleted within 24 hours.

Post time 2022-3-20 17:51:31

: This post has been completed
Completed attachments will be deleted within 24 hours.

[JAMA] Association of Rivaroxaban vs Apixaban With Major Ischemic or Hemorrhagic Events in Patients With Atrial Fibrillation

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today